AOD9604 is supplied strictly for laboratory research use and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any condition
Sun C, Du Z, Liu X, et al
The half-life of elimination is about 1.6 hours after intravenous administration
Based on these researches, clinical trials targeting HO-1 should be carried out to evaluate its application in the treatment of DN, so as to provide evidence for clinical application
Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H 2 O : 50 mg/mL (Need ultrasonic) Purity & Documentation Data Sheet (292 KB) SDS (252 KB) English - EN (252 KB) Franais - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Espaol - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB) Handling Instructions (2659 KB) References [1]